Prilosec OTC Review: Two Advisory Cmte. Members Weigh In Without Voting
Executive Summary
An upcoming publication by FDA's Gastrointestinal Drugs Advisory Committee chairman will suggest a potential link between proton pump inhibitor therapy and the proliferation of pre-existing esophageal adenocarcinoma